medRxiv : the preprint server for health sciences
March 11, 2025
Kaoru Nashiro, B Rael Cahn, Paul Choi et al.
2 citations
preprint
A week of daily mindfulness meditation with slow breathing lowered blood levels of amyloid beta, a protein linked to Alzheimer's disease, while the same practice with normal breathing raised those levels. A control group that did not meditate showed no change. The results suggest that slow breathing may be a mechanism through which meditation influences biological pathways relevant to Alzheimer's disease.
medRxiv : the preprint server for health sciences
October 21, 2024
Pascal Grumbach, Jan Kasper, Joerg F. Hipp et al.
1 citation
preprint
Autism spectrum disorder involves altered resting-state brain function, and an imbalance between excitation and inhibition is a proposed mechanism. In two large independent cohorts, individuals with autism consistently showed reduced local brain activity in default mode network nodes and increased activity in temporal regions, cerebellum, and brainstem. These activity changes spatially overlapped with multiple neurotransmitter systems, including dopamine, glutamate, GABA, and acetylcholine. The NMDA-antagonist ketamine, but not the GABA-potentiator midazolam, induced activity changes resembling those seen in autism, suggesting that pharmacologically shifting the excitation-inhibition balance can mimic autism-related brain alterations.
medRxiv : the preprint server for health sciences
January 16, 2026
Colleen Caleshu, Maryann Campion, Jehannine J Austin et al.
Mindfulness meditation may reduce burnout and stress among genetic counselors. In a randomized controlled trial with 397 clinical genetic counselors in the US, those assigned to 10 minutes of daily app-based mindfulness meditation for eight weeks showed lower burnout and stress compared to a no-meditation control group. The effect on burnout was large. However, the active control meditation designed to mimic mindfulness without its techniques did not perform as an inert control, so the primary comparison between mindfulness and active control was inconclusive. Further research with more diverse samples and better controls is needed.
medRxiv : the preprint server for health sciences
May 27, 2025
Colin G Walsh, Michael Ripperger, Thomas H McCoy et al.
preprint
Predicting which people with major depressive disorder will develop treatment-resistant depression from electronic health record data alone is not yet accurate enough for clinical use. Models built using sociodemographic features, medications, and diagnosis codes from three large U.S. health systems performed only slightly better than chance, with discrimination scores (AUROC) between 0.58 and 0.64 within the same health system and dropping to 0.51–0.58 when applied to a different system. Agreement between models from different sites was low, with concordance correlation coefficients ranging from 0.13 to 0.38. Age and sex were the most important features driving differences in model predictions. The findings suggest that readily available electronic health record data are insufficient for reliable prediction and that further improvement will require additional data types.
medRxiv : the preprint server for health sciences
January 18, 2025
Stephanie C. DeMasi, Brant Imhoff, Ariel A. Lewis et al.
preprint
Among critically ill adults undergoing emergency tracheal intubation, it is uncertain whether the choice of ketamine or etomidate for induction of anesthesia affects patient outcomes. The Randomized trial of Sedative choice for Intubation (RSI) is a pragmatic, multicenter trial enrolling 2,364 patients across 14 U.S. sites to compare ketamine versus etomidate. The primary outcome is all-cause, 28-day in-hospital mortality; a secondary outcome is cardiovascular collapse during intubation. Enrollment began in April 2022 and is expected to conclude in 2025. Prespecifying the protocol and statistical analysis plan before enrollment ends increases the trial's rigor, reproducibility, and transparency.
medRxiv : the preprint server for health sciences
November 2, 2024
Theresa R. Lii, Josephine R. Flohr, Robin L. Okada et al.
preprint
The placebo antidepressant response was weaker in depressed patients who were already taking opioid medications, independent of their pain levels. In a re-analysis of a randomized trial, patients on chronic opioid therapy who received a placebo showed depression scores 10 points higher on the Montgomery-Åsberg Depression Rating Scale (MADRS) across 1 to 14 days after treatment, indicating less improvement. When measured as percent change, opioid users experienced 38.4% less improvement than non-users. For patients who received ketamine, baseline opioid use did not significantly affect depression scores. Pain intensity did not predict depression outcomes, and the link between depression and pain was negligible. These results come from a small, unregistered post hoc analysis and require confirmation.
medRxiv : the preprint server for health sciences
July 14, 2026
Ali J Zarrabi, Tanja Mletzko, George Grant et al.
In an open-label pilot study, psilocybin-assisted therapy (PAT) was tested in cancer patients with demoralization and chronic pain within a multidisciplinary palliative care setting. Ten of eleven enrolled participants received a single 25 mg oral dose of psilocybin with preparation, monitoring, and integration. The intervention was safe and feasible, with no serious adverse events and complete retention. All dosed participants found it highly acceptable; 70% rated it among the five most meaningful experiences of their lives and 60% among the five most spiritually significant. By study endpoint, 90% no longer met criteria for clinically significant demoralization and had pain scores below the enrollment threshold.
medRxiv : the preprint server for health sciences
September 27, 2025
Grace M Elliott, Madeline M Robertson, Celine E Locklear et al.
preprint
People who experience alcohol-related blackouts show reduced resting-state alpha peak power over the primary motor cortex in a sex-specific pattern. In Experiment 1, adult females with a history of blackout had lower alpha peak power over the primary motor cortex compared to those without such history, while in males, aperiodic slope over the right primary motor cortex was negatively correlated with lifetime blackout score. In Experiment 2, more frequent parasomnia episodes were associated with reduced alpha peak power across both sexes. These results provide initial evidence for shared neurophysiological phenotypes between certain parasomnias and alcohol-related blackout, suggesting underlying dysfunction of motor inhibition that allows coordinated motor activity to persist during intoxication or sleep.
medRxiv : the preprint server for health sciences
November 11, 2024
Sophia G Girgenti, Isabella Dallasta, Erin Lawrence et al.
preprint
An 8-week online modified Mindfulness Based Stress Reduction (MBSR) course modestly improved cognitive performance in patients recovering from minor stroke, particularly in processing speed, executive function, and global cognition, compared to a traditional stroke support group. Thirty patients with subacute minor stroke were randomized to either intervention. Both groups showed increased cognitive scores three months post-stroke, but the MBSR group had moderately greater improvements. Engagement was low in both groups and did not correlate with better outcomes. The authors suggest MBSR may be more effective in the chronic recovery stage when patients can participate more fully.
medRxiv : the preprint server for health sciences
August 17, 2024
Charles R Conway, Ben Julian A Palanca, Thomas Zeffiro et al.
preprint
Nitrous oxide (N2O) reduces functional connectivity in mood-related brain networks in people with treatment-resistant major depression (TRD) but increases connectivity in healthy controls. In a crossover trial, 14 TRD patients and 16 healthy controls received one-hour inhalations of 50% N2O or placebo. Resting-state fMRI scans before, 2 hours, and 24 hours after inhalation showed that N2O progressively decreased connectivity in TRD patients across five brain networks (salience, default mode, reward, cingulo-opercular, and the dorsal nexus), while increasing connectivity in controls. The findings suggest N2O's antidepressant effects involve specific alterations in depressed brains.
medRxiv : the preprint server for health sciences
March 5, 2024
Emanuele Rg Plini, Michael C Melnychuk, Paul M Dockree
preprint
Long-term meditators show greater structural integrity of the pineal gland and a younger estimated brain age compared to controls. Among meditators, more lifetime hours of practice are associated with higher pineal gland signal intensity, but not with brain-age maintenance. Greater pineal integrity and younger brain age are correlated in meditators. The findings suggest meditation may support pineal gland health and slow brain aging, possibly through melatonin's roles in sleep, immune function, and neural regeneration.